Financials data is unavailable for this security.
View more
Year on year Heart Test Laboratories Inc had net income fall 3.95% from a loss of 6.35m to a larger loss of 6.61m despite a 261.17% increase in revenues from 5.15k to 18.60k.
Gross margin | 67.31% |
---|---|
Net profit margin | -39,193.76% |
Operating margin | -37,907.42% |
Return on assets | -135.14% |
---|---|
Return on equity | -269.33% |
Return on investment | -193.38% |
More ▼
Cash flow in USDView more
In 2024, Heart Test Laboratories Inc increased its cash reserves by 249.76%, or 4.15m. Cash Flow from Financing totalled 10.34m or 55,605.59% of revenues. In addition the company used 6.07m for operations while cash used for investing totalled 125.27k.
Cash flow per share | -0.4388 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 6.55 |
---|---|
Tangible book value per share | 4.79 |
More ▼
Balance sheet in USDView more
Current ratio | 4.49 |
---|---|
Quick ratio | 4.02 |
Total debt/total equity | 0.0843 |
---|---|
Total debt/total capital | 0.0777 |
More ▼